Overview of azathioprine treatment in multiple sclerosis

The Lancet

Volumn 338, Issue 8774, 1991, Pages 1051-1055

  Yudkin, P L ^a   Ellison, G W ^b   Ghezzi, A ^c   Goodkin, D E ^d   Hughes, R A C ^e   McPherson, K ^f   Mertin, J ^g   Milanese, C ^h  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Centre Studi Sclerosi Multipla   (Italy)

^d Mellen Center for Multiple Sclerosis Treatment and Research   (United States)

^e GUY S HOSPITAL   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g Therapiezentrum Burgau   (Germany)

^h DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

AZATHIOPRINE; DISABILITY EVALUATION; FOLLOW-UP STUDIES; HUMAN; META-ANALYSIS; MULTIPLE SCLEROSIS; PROBABILITY; RANDOMIZED CONTROLLED TRIALS; RECURRENCE;

EID: 0025986898     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(91)91909-E     Document Type: Article

References (26)

1. Why do we need systematic overviews of randomised trials?
2. Immunological treatment for multiple sclerosis
3. The disability status scale for multiple sclerosis: apologia for DSS sua
4. Problems of experimental trials of therapy in multiple sclerosis report by the panel on evaluation of experimental trials of therapy in multiple sclerosis
5. Intensive immunosuppression in progressive multiple sclerosis: a randomised three-arm study of high dose intravenous cyclophosphamide, plasma exchange, and ACTH
6. Some aspects of natural history of disseminated sclerosis
7. An illness severity score for multiple sclerosis
8. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo
9. Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone
10. Therapie der multiplen Sclerose mit Levamisol und Azathioprin—Vergleich der Wirksamkeit einer "immunstimulierenden" und "immun-suppressiven" Behandlung
11. Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole-peg-tests
12. Long-term treatment of multiple sclerosis with azathioprine
13. Prolonged azathioprine treatment of non-remitting multiple sclerosis
14. Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report
15. Azathioprine in treatment of multiple sclerosis: final results of a 4½-year controlled study of its effectiveness covering 115 patients
16. Double-masked trial of azathioprine in multiple sclerosis
17. Double blind controlled randomised study on azathioprine efficacy in multiple sclerosis: preliminary results
18. Follow-up evaluation after at least two years' treatment with azathioprine in a double-blind trial
19. Clinical controlled randomized trial of azathioprine in multiple sclerosis
20. A placebo-controlled randomised, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis
21. The efficacy of azathioprine in relapsing-remitting multiple sclerosis
22. The combination of estimates from different experiments
23. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial
24. An assessment of disability rating in multiple sclerosis
25. Long term immunosuppression in multiple sclerosis. A 15 years' study with azathioprine
26. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment